Stocks and Investing
Stocks and Investing
Tue, June 25, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Francois Brisebois Initiated (ADVM) at Buy and Held Target at $25 on, Jun 25th, 2024
Francois Brisebois of Oppenheimer, Initiated "Adverum Biotechnologies, Inc." (ADVM) at Buy and Held Target at $25 on, Jun 25th, 2024.
Francois has made no other calls on ADVM in the last 4 months.
There are 5 other peers that have a rating on ADVM. Out of the 5 peers that are also analyzing ADVM, 1 agrees with Francois's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Luca Issi of "RBC Capital" Maintained at Hold with Decreased Target to $20 on, Tuesday, March 19th, 2024
These are the ratings of the 4 analyists that currently disagree with Francois
- Joon Lee of "Truist Securities" Maintained at Strong Buy and Held Target at $60 on, Wednesday, May 15th, 2024
- Matthew Caufield of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $30 on, Friday, May 10th, 2024
- Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $22 on, Monday, April 29th, 2024
- Daniil Gataulin of "Chardan Capital" Reiterated at Strong Buy with Increased Target to $40 on, Tuesday, March 19th, 2024
Contributing Sources